Virtual Network's Login.
There are only two weeks left to register for #ESHMM2023.
Proceed now and join us in Berlin!
About the Conference:
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.
They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.
• How I treat smoldering myeloma
• How I treat newly diagnosed multiple myeloma
• From risk stratification to risk-based therapy?
• Should we use MRD testing to determine therapy in multiple myeloma?
• Is there a future role of autologous stem cell transplantation?
• How I treat relapsed multiple myeloma
• The FDA/EMEA and Foundations perspective on multiple myeloma
• Should every patient receive daratumumab in first line?
• You can’t be immune for immune therapy anymore
• Other plasma cell dyscrasias
• The future of multiple myeloma
This educational conference has been approved for 17 CME-CPD credit points
by the European Board for Accreditation in Haematology (EBAH)!
For more information, click here!
With the support of*:
Major Conference Partners
*******
Level 1 Conference Partner
*******
Level 2 Conference Partners
*******
Supporting Conference Partner
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.
